4月13日乙肝药物概念股市复盘讯息:
开盘:报涨
康泰生物(144.390,9.310,6.892%)领涨,沃森生物(44.000,1.100,2.564%)、梅花生物(6.140,0.070,1.153%)、辰欣药业(13.400,0.070,0.525%)等跟涨。
早盘:报涨
沃森生物(45.230,2.330,5.431%)领涨,康泰生物(141.820,6.740,4.990%)、梅花生物(6.150,0.080,1.318%)、辰欣药业(13.420,0.090,0.675%)等跟涨。
上午收盘:报跌
智飞生物(176.650,-9.100,-4.899%)领跌,博雅生物(30.110,-1.510,-4.775%)、恒瑞医药(89.330,-1.870,-2.050%)、双鹭药业(10.010,-0.140,-1.379%)等跟跌。
午后:报跌
智飞生物(174.850,-10.900,-5.868%)领跌,博雅生物(30.050,-1.570,-4.965%)、恒瑞医药(89.450,-1.750,-1.919%)、双鹭药业(9.990,-0.160,-1.576%)、贵州百灵(7.580,-0.110,-1.430%)等跟跌。
尾盘:报跌
智飞生物(175.350,-10.400,-5.599%)领跌,博雅生物(29.990,-1.630,-5.155%)、双鹭药业(9.940,-0.210,-2.069%)等跟跌。
收盘:报跌
博雅生物(29.750,-1.870,-5.914%)领跌,智飞生物(176.200,-9.550,-5.141%)、贵州百灵(7.510,-0.180,-2.341%)、双鹭药业(9.930,-0.220,-2.167%)、华北制药(8.850,-0.190,-2.102%)等跟跌。
数据由南方财富网提供,仅供参考,不构成投资建议,据此操作,风险自担。股市有风险,投资需谨慎。